Draft guidance released by the FDA aims to clarify scenarios where changes to medical device design warrant a recall and help medtech firms differentiate those cases from product enhancements that do not constitute a recall. The guidance also outlines the regulatory standards for reporting a recall or product enhancement.

Related Summaries